| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.98B | 26.62B | 25.02B | 21.59B | 12.17B | 1.91B |
| Gross Profit | 10.13B | 7.88B | 9.38B | 7.28B | 412.00M | -2.75B |
| EBITDA | 7.23B | 6.91B | 6.23B | 4.37B | -2.20B | -5.69B |
| Net Income | 3.10B | 2.76B | 1.92B | -74.00M | -6.09B | -9.50B |
Balance Sheet | ||||||
| Total Assets | 51.57B | 51.69B | 49.06B | 49.12B | 51.70B | 53.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.42B | 1.93B | 1.21B | 2.42B | 4.03B | 9.14B |
| Total Debt | 26.61B | 27.99B | 28.88B | 31.89B | 35.88B | 34.61B |
| Total Liabilities | 38.52B | 39.40B | 39.81B | 42.24B | 44.64B | 41.20B |
| Stockholders Equity | 13.03B | 12.28B | 9.25B | 6.88B | 7.06B | 12.14B |
Cash Flow | ||||||
| Free Cash Flow | 2.99B | 2.61B | 1.30B | 997.00M | -6.61B | -7.72B |
| Operating Cash Flow | 6.56B | 6.22B | 5.92B | 4.28B | -1.67B | -4.11B |
| Investing Cash Flow | -3.31B | -3.32B | -4.54B | -2.81B | -4.77B | -3.54B |
| Financing Cash Flow | -2.67B | -2.19B | -2.58B | -5.09B | 3.58B | 6.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $2.44B | 27.43 | 14.09% | 0.79% | 9.47% | 18.45% | |
73 Outperform | $37.55B | -150.62 | 146.91% | ― | 20.78% | 119.41% | |
66 Neutral | $68.68B | 19.74 | 45.86% | 1.09% | 9.74% | 34.02% | |
64 Neutral | $35.94B | 42.16 | 26.22% | ― | 6.10% | 45.44% | |
62 Neutral | $1.35B | 40.09 | 11.75% | ― | 19.15% | 7.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | $7.48B | 20.40 | 27.04% | ― | 6.53% | -35.30% |